- MEDIUM
- Business
- Tier 1
- Hard News
Align Technology Announces $270 Million Stock Repurchase
- Source
- Dentistry Today
- Author
- Dentistry Today
- Originally at
- dentistrytoday.com(opens in a new tab)
Summary and scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol. Not the original publisher.
Why it matters for dental
Align Technology’s $270 million stock repurchase is a capital-allocation move by the maker of Invisalign aligners, iTero scanners, and exocad software; practices that purchase those products may see no direct change in pricing, availability, or clinical workflow.
Key points
- 01
Align Technology, Inc. entered an accelerated stock repurchase agreement with Goldman Sachs to buy back $270 million of its common stock under the $1.0 billion repurchase program approved by its Board in April 2025.
- 02
Align CFO John Morici stated that the $270 million ASR fulfills the July share-repurchase commitment and is expected to bring total 2026 repurchases to approximately $500 million.
- 03
Align will prepay $270 million to Goldman Sachs; the final share count will be based on the volume-weighted average price of Align common stock during the ASR term, less an agreed-upon discount.
- 04
The ASR is expected to be completed on or about December 29, 2026, and will be funded with Align’s cash on hand; approximately $330 million will remain available under the program after this transaction.
Who should care
- Owner
- DSO
Read the original
Dentistry Today
Full reporting and any paywalled content live on dentistrytoday.com. We summarize and score; we do not republish.